| P2093 | author name string | E. Edwards | |
| | C. R. Ashby | |
| | R. Y. Wang | |
| | Ashby CR Jr | |
| | Y. Minabe | |
| P2860 | cites work | Molecular Pharmacology | Q1943386 |
| | Interaction of the atypical neuroleptic clozapine with 5-HT3 receptors in the cerebral cortex and superior cervical ganglion of the rat. | Q48932614 |
| | Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone | Q50344150 |
| | Denervation supersensitivity to serotonin in rat forebrain: Single cell studies | Q66971421 |
| | Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients | Q69118949 |
| | Characterization of 5-hydroxytryptamine3 receptors in the medial prefrontal cortex: a microiontophoretic study | Q69364586 |
| | Differential effect of typical and atypical antipsychotic drugs on the suppressant action of 2-methylserotonin on medical prefrontal cortical cells: a microiontophoretic study | Q69375245 |
| | Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study | Q70063642 |
| | RMI-81,582, a novel antipsychotic drug | Q72421699 |
| | Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons | Q28277274 |
| | Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain | Q28305760 |
| | Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain | Q28360220 |
| | Functional correlates of serotonin 5-HT1 recognition sites | Q34172554 |
| | Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine | Q34558205 |
| | Thioridazine Stimulates Prolactin Secretion in Man | Q40336766 |
| | Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve | Q42565964 |
| | Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron). | Q44421662 |
| | [3H]zacopride: ligand for the identification of 5-HT3 recognition sites | Q46157404 |
| | Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding | Q48170120 |
| | CGS 10746B: an atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective doses | Q48309716 |
| | The Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients | Q48398999 |
| | Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens. | Q48422329 |
| | Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells. | Q48887781 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 155-161 | |
| P577 | publication date | 1991-07-01 | |
| P1433 | published in | Synapse | Q7662025 |
| P1476 | title | Comparison of the effects of various typical and atypical antipsychotic drugs on the suppressant action of 2-methylserotonin on medial prefrontal cortical cells in the rat | |
| P478 | volume | 8 | |